← Eichor
Condition: Primary Immune Deficiency Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Primary Immune Deficiency Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodefic
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01306019Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Phase 2 · 9 location(s) · New York Medical College · NCT03266640Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Phase 1/Phase 2 · 7 location(s) · New York Medical College · NCT04197596Genetic Basis of Immunodeficiency
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00055172Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Phase 1 · 3 location(s) · Children's National Research Institute · NCT04691622Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06669949STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · 51 location(s) · ADARx Pharmaceuticals, Inc. · NCT06960213Autologous Gene Therapy for Artemis-Deficient SCID
Phase 1/Phase 2 · 1 location(s) · University of California, San Francisco · NCT03538899Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
NA · 1 location(s) · Gazi University · NCT06092528Primitive Immunodeficiency, Intrauterine Devices and Menstrual Hygiene Products
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06519734Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema
Phase 3 · 32 location(s) · Pharvaris Netherlands B.V. · NCT07266805SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Pathogenic Study of Adult Immune Enteropathies
Phase N/A · 4 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04280510Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06169150Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT05193552Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Phase 2 · 8 location(s) · New York Medical College · NCT03266653Detection and Characterization of Infections and Infection Susceptibility
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00404560Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Phase N/A · 7 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00246857
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.